Showing results (1231-1240 of 3,971) with videos related to

Sort By:
Pageof 398
Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu|December 6, 2014
[Spectroscopic characteristics study of morganite from Mozambique]Zuo-wei Yin, Xiao-lu Li, De-qing Bao, et al.
Current Microbiology|June 8, 2013
Screening of Actinobacillus pleuropneumoniae LuxS inhibitorsLu Li, Lili Sun, Yunfeng Song, et al.
Cytotechnology|February 17, 2025
TGF-β1 induces ROS to activate ferroptosis via the ERK1/2-WISP1 pathway to promote the progression of renal tubular epithelial cell fibrosisYi Zhou, Fengwu Luan, Xiaonan Feng, et al.
Molecules (Basel, Switzerland)|November 27, 2024
Perborate Activated Peroxymonosulfate Process for Improving the Coagulation Efficiency of <i>Microcystis aeruginosa</i> by Polymeric Aluminum ChlorideFan Chen, Lu Li, Shunfan Qiu, et al.
Frontiers in Psychology|December 12, 2024
Association of grip strength, sleep duration, and comorbidities with depressive symptoms in middle-aged and older patients with chronic lung diseases: a cross-sectional network analysis based on CHARLS dataLu Li, Jiaqi Meng, Yinxiang Wu, et al.
The Science of the Total Environment|November 5, 2024
Toxicokinetics and responses of multiple biomarkers of sediment-associated fluoroquinolones in an ecologically important freshwater snail Bellamya aeruginosaMeng Wang, Xiaoxu Zhang, Lu Li, et al.
Clinical Nutrition ESPEN|November 19, 2025
Abnormalities of serum phosphorus at hospital admission were associated with length of hospital stays and mortality in patients with cancerLu Li, Chen Chen, Yiquan Zhou, et al.
Nanoscale|January 16, 2020
Construction of hierarchical yolk-shell nanospheres organized by ultrafine Janus subunits for efficient overall water splittingQi Zhang, Bingqiu Liu, Yue Ji, et al.
Journal of Oral Microbiology|November 21, 2022
<i>Fusobacterium nucleatum</i> and its associated systemic diseases: epidemiologic studies and possible mechanismsZixin Fan, Pengzhou Tang, Cheng Li, et al.
Frontiers in Pharmacology|June 20, 2022
Immune Checkpoint Inhibitors Plus an Anti-VEGF Antibody as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis and Cost-Effectiveness AnalysisLu Li, Shilei Yang, Yanwei Chen, et al.
Pageof 398